Smith & Nephew plc is a healthcare company in the United Kingdom with a medium risk ESG score of 23.5. They specialize in designing, manufacturing, and marketing orthopedic devices, sports medicine technology, arthroscopic technologies, and wound-care solutions. About 41% of their revenue comes from orthopedic products, 30% from sports medicine and ENT, and the remaining 29% from advanced wound therapy. They generate roughly half of their revenue from the United States, over 30% from other developed markets, and the rest from emerging markets.